Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
The Respiratory Syncytial Virus Vaccine and Monoclonal Antibody Landscape: The Road to Global Access
2024
· University Medical Center Utrecht,
· Yenepoya University,
· University of Edinburgh,
· National Institutes of Health (NIH),
· London School of Hygiene and Tropical Medicine,
· London School of Hygiene & Tropical Medicine
This article is about the fight against respiratory syncytial virus (RSV), a major cause of illness in infants and older adults. It describes new vaccines …
Ask aRCie
Beyfortus-nirsevimab injection (Drug Label Information)
2024
· National Library of Medicine
This webpage provides drug label information for the Beyfortus- nirsevimab injection. It describes the drug's dosage, forms, and strengths. Beyfortus is given as an injection …
Nirsevimab (Beyfortus) Product & Ordering Information
This webpage provides information about nirsevimab (Beyfortus), describing the different doses available, how to order and store it, and its cost. Practices need to forecast …
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
2024
· Centers for Disease Control and Prevention (CDC),
· U.S. Public Health Service,
· University of Rochester,
· University of Cincinnati,
· Cincinnati Children's Hospital Medical Center,
· Vanderbilt University,
· Texas Children's Hospital,
· Baylor College of Medicine,
· University of Washington,
· University of Pittsburgh,
· Children's Mercy Kansas City
This study looks at the impact of respiratory syncytial virus (RSV) in young children during the 2023-2024 season. It describes how two new RSV prevention …
Universal Infant Immunisation Against Respiratory Syncytial Virus and European Inequalities: The Pandemics Lesson Has Not Been Learnt
2023
· Hôpital Antoine-Béclère AP-HP,
· Université Paris-Saclay,
· American College of Emergency Physicians,
· Hospital General Universitario Gregorio Marañón,
· St. Marien Children's Hospital,
· University Medical Centre Utrecht,
· Respiratory Syncytial Virus NETwork (ReSViNET) Foundation,
· University Hospital of Padova
This comment discusses the challenges of implementing universal infant immunization against respiratory syncytial virus (RSV) in Europe. RSV is a major cause of illness in …
Potential Effects on Elderly People From Nirsevimab Use in Infants
2024
· World Health Organization (WHO),
· Instituto de Estudios de Ciencias de la Salud de Castilla y León, ICSCYL,
· Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECC),
· University of Valladolid
This article is about nirsevimab, a new treatment for infants to prevent severe RSV disease. It describes how using nirsevimab in babies might help protect …
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
This article describes the use of nirsevimab, a new drug approved in 2023, to prevent severe respiratory syncytial virus (RSV) disease in infants and young …
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024
2024
· Centers for Disease Control and Prevention (CDC),
· Vanderbilt University,
· Seattle Children's Hospital,
· Baylor College of Medicine,
· University of Rochester
This study examines the effectiveness of nirsevimab, a monoclonal antibody, in preventing RSV-related hospitalizations in infants during their first RSV season. Conducted from October 2023 …
What U.S. Obstetricians Need to Know About Respiratory Syncytial Virus
This review article discusses two preventive option for the prevention of RSV in infants: a maternal vaccine and a monoclonal antibody for infants. The FDA …
Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024
This article is about a study on RSV vaccination for pregnant women and their babies in the U.S. It describes how RSV is a common …